MAXIPIME Side Effects

5793613-6 | Coma, Febrile Neutropenia, Renal Failure, Septic Shock
on Jun 23, 2008 Male patient from BELGIUM , 72 years of age, was diagnosed with febrile neutropenia and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: coma, febrile neutropenia, renal failure, septic shock. Maxipime dosage: . During the same period patient was treated with AMUKIN (View Amukin Review and Amukin Label ), GLAZIDIM (View Glazidim Review and Glazidim Label ). Patient was hospitalized.

5773734-4 | Hepatic Enzyme Increased
Patient was taking Maxipime (View Usage). Patient had the following side effects: hepatic enzyme increased on Jun 11, 2008 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with pleural effusion, lung infection and. Maxipime dosage: . During the same period patient was treated with VANCOMYCIN (Dose Reduced To 1 Gm Every 24 Hrs.) (View Vancomycin Review and Vancomycin Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), LASIX (View Lasix Review and Lasix Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

5750482-8 | Pruritus, Rash Erythematous, Rash Maculo-papular
Adverse event was reported on May 23, 2008 by a Female patient taking Maxipime (View Usage) (Dosage: 1.5gm Iv Q12) was diagnosed with cystic fibrosis and. Location: UNITED STATES , child 12 years of age, weighting 52.00 lb, After Maxipime was administered, patient had the following side effects: pruritus, rash erythematous, rash maculo-papular.

5739201-9 | Pancytopenia, Sepsis
on May 12, 2008 Male patient from JAPAN , 30 years of age, was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia, sepsis (What is sepsis?). Maxipime dosage: .


5721502-1 | Agitation, Aphasia, Cardiopulmonary Failure, Cheyne-stokes Respiration, Coma, Depressed Level Of Consciousness, Myoclonus
on Apr 23, 2008 Male patient from BELGIUM , 84 years of age, was diagnosed with pneumonia bacterial and was treated with Maxipime (View Usage). Patient had the following side effects: agitation, aphasia (What is aphasia?), cardiopulmonary failure, cheyne-stokes respiration, coma, depressed level of consciousness, myoclonus. Maxipime dosage: October 30-november 1 No Maxipime. During the same period patient was treated with CIPROFLOXACIN HCL (No Antibiotics On Dialysis Days) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

5720737-1 | Agitation, Aphasia, Choreoathetosis, Coma, Convulsion, Depressed Level Of Consciousness, Metabolic Encephalopathy, Myoclonus
Patient was taking Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: agitation, aphasia (What is aphasia?), choreoathetosis, coma, convulsion, depressed level of consciousness, metabolic encephalopathy, myoclonus on Apr 23, 2008 from BELGIUM Additional patient health information: Female patient , 82 years of age, was diagnosed with pseudomonas infection, escherichia sepsis and. Maxipime dosage: 1 Gram + 1 Gram Iv After Dialysis (dates Not Specified). During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ZANTAC (View Zantac Review and Zantac Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KAYEXALATE (View Kayexalate Review and Kayexalate Label ). Patient was hospitalized.

5720539-6 | Chorea, Coma, Myoclonus
Adverse event was reported on Apr 23, 2008 by a Male patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with infection (What is infection?), chronic obstructive pulmonary disease and. Location: BELGIUM , 71 years of age, weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: chorea, coma, myoclonus. During the same period patient was treated with MERONEM (View Meronem Review and Meronem Label ), EUPHYLLINE (2 Ampoulles Iv/24 Hours) (View Euphylline Review and Euphylline Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), LYSOMUCIL (3 Amp) (View Lysomucil Review and Lysomucil Label ). Patient was hospitalized.

5715808-X | Aphasia, Apoptosis, Dysarthria, Hallucination
on Apr 22, 2008 Male patient from UNITED STATES , 47 years of age, was treated with Maxipime (View Usage). Patient had the following side effects: aphasia (What is aphasia?), apoptosis, dysarthria, hallucination. Maxipime dosage: . During the same period patient was treated with OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ). Patient was hospitalized.

5605482-5 | Febrile Neutropenia, Haemoglobin Decreased, Interstitial Lung Disease, Neutrophil Count Decreased
on Jan 28, 2008 Female patient from UNITED STATES , 65 years of age, was diagnosed with febrile neutropenia, breast cancer (What is breast cancer?), neutrophil count decreased and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: febrile neutropenia, haemoglobin decreased, interstitial lung disease, neutrophil count decreased. Maxipime dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), GRAN (One Dosage Form = 75 Ug From 20-aug-27-aug And 17-sep-2007 To 19-sep-2007.) (View Gran Review and Gran Label ). Patient was hospitalized.

5577677-0 | Depressed Level Of Consciousness, Dyskinesia, Nerve Injury
Patient was taking Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, dyskinesia, nerve injury on Dec 27, 2007 from JAPAN Additional patient health information: Female patient , 92 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Maxipime dosage: . During the same period patient was treated with THYRADIN S (View Thyradin S Review and Thyradin S Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), TOWARAT L (View Towarat L Review and Towarat L Label ), SELBEX (View Selbex Review and Selbex Label ), NIKORANMART (View Nikoranmart Review and Nikoranmart Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

5541722-9 | Febrile Neutropenia, Haemoglobin Decreased, Interstitial Lung Disease, Neutrophil Count Decreased
Adverse event was reported on Oct 01, 2007 by a Female patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with febrile neutropenia, breast cancer (What is breast cancer?), neutrophil count decreased and. Location: UNITED STATES , 65 years of age, Patient had the following side effects: febrile neutropenia, haemoglobin decreased, interstitial lung disease, neutrophil count decreased. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), GRAN (One Dosage Form = 75 Ug From 20-aug-27-aug And 17-sep-2007 To 19-sep-2007.) (View Gran Review and Gran Label ). Patient was hospitalized.

5541722-9 | Febrile Neutropenia, Haemoglobin Decreased, Interstitial Lung Disease, Neutrophil Count Decreased
on Oct 01, 2007 Female patient from UNITED STATES , 65 years of age, was diagnosed with febrile neutropenia, breast cancer (What is breast cancer?), neutrophil count decreased and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: febrile neutropenia, haemoglobin decreased, interstitial lung disease, neutrophil count decreased. Maxipime dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN HCL (View Epirubicin Hcl Review and Epirubicin Hcl Label ), GRAN (One Dosage Form = 75 Ug From 20-aug-27-aug And 17-sep-2007 To 19-sep-2007.) (View Gran Review and Gran Label ). Patient was hospitalized.

5531491-0 | Interstitial Lung Disease
on Nov 28, 2007 Female patient from JAPAN , 69 years of age, was diagnosed with bronchopneumonia and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Maxipime dosage: . During the same period patient was treated with MEROPEN (View Meropen Review and Meropen Label ), PAZUCROSS (View Pazucross Review and Pazucross Label ), PEGINTERFERON ALFA 2B (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ), REBETOL (View Rebetol Review and Rebetol Label ). Patient was hospitalized.

5520362-1 | Arthralgia, Infusion Related Reaction, Myalgia, Pyrexia, Serum Sickness, Sluggishness
Patient was taking Maxipime (View Usage). Patient had the following side effects: arthralgia, infusion related reaction, myalgia, pyrexia, serum sickness, sluggishness on Nov 16, 2007 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 101.0 lb, was diagnosed with cystic fibrosis, pseudomonas infection, staphylococcal infection (What is staphylococcal infection?) and. Maxipime dosage: 2gm Iv Over 30-60 Min Q12 Hours Iv. During the same period patient was treated with VANCOMYCIN (1200 Mg Q24 Hours Iv) (View Vancomycin Review and Vancomycin Label ).

5515826-0 | Febrile Neutropenia, Haemoglobin Decreased, Interstitial Lung Disease, Neutrophil Count Decreased
Adverse event was reported on Nov 06, 2007 by a Female patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with febrile neutropenia, breast cancer (What is breast cancer?), neutrophil count decreased and. Location: UNITED STATES , 65 years of age, After Maxipime was administered, patient had the following side effects: febrile neutropenia, haemoglobin decreased, interstitial lung disease, neutrophil count decreased. During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), GRAN (One Dosage Form = 75 Ug From 20-aug-27-aug And 17-sep-2007 To 19-sep-2007.) (View Gran Review and Gran Label ). Patient was hospitalized.

5476011-4 | Interstitial Lung Disease
on Sep 25, 2007 Female patient from JAPAN , 65 years of age, was diagnosed with febrile neutropenia and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Maxipime dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), GRAN (View Gran Review and Gran Label ).

5469704-6 | Interstitial Lung Disease
on Sep 25, 2007 Female patient from JAPAN , 65 years of age, was diagnosed with febrile neutropenia and was treated with Maxipime (View Usage). Patient had the following side effects: interstitial lung disease. Maxipime dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), GRAN (View Gran Review and Gran Label ).

5469321-8 | Interstitial Lung Disease
Patient was taking Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: interstitial lung disease on Sep 25, 2007 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with febrile neutropenia and. Maxipime dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), GRAN (View Gran Review and Gran Label ).

5444315-7 | Eosinophilic Pneumonia
Adverse event was reported on Sep 04, 2007 by a Male patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: JAPAN , 19 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilic pneumonia. Patient was hospitalized.

5406011-1 | Creatinine Renal Clearance Decreased, Incoherent, Lethargy, Unresponsive To Stimuli
on Aug 02, 2007 Male patient from UNITED STATES , 84 years of age, weighting 228.0 lb, was diagnosed with device related infection, streptococcal infection (What is streptococcal infection?) and was treated with Maxipime (View Usage). Patient had the following side effects: creatinine renal clearance decreased, incoherent, lethargy, unresponsive to stimuli. Maxipime dosage: 2 G Iv Q 12 H. During the same period patient was treated with DUONEB (View Duoneb Review and Duoneb Label ), LOVENOX (View Lovenox Review and Lovenox Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), OLIGOFRUCTOSE (View Oligofructose Review and Oligofructose Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized.

5398018-8 | Confusional State
on Jan 02, 2007 Male patient from UNITED STATES , 80 years of age, was diagnosed with klebsiella infection, clostridial infection and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: confusional state. Maxipime dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), COREG (View Coreg Review and Coreg Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

5398017-6 | Chromaturia
Patient was taking Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: chromaturia on Nov 14, 2006 from UNITED STATES Additional patient health information: Female patient , 75 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Maxipime dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5396582-6 | Sepsis
Adverse event was reported on Jul 24, 2007 by a Male patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?) and. Location: SINGAPORE , 48 years of age, Patient had the following side effects: sepsis (What is sepsis?). During the same period patient was treated with MERONEM (View Meronem Review and Meronem Label ), CIPROXIN (View Ciproxin Review and Ciproxin Label ).

5366455-3 | Convulsion, Depressed Level Of Consciousness, Strabismus
on Jun 18, 2007 Female patient from JAPAN , 95 years of age, was diagnosed with pneumonia aspiration and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: convulsion, depressed level of consciousness, strabismus. Maxipime dosage: . Patient was hospitalized and became disabled.

5323638-6 | Convulsion, Ventricular Tachycardia
on May 09, 2007 Female patient from JAPAN , 77 years of age, was diagnosed with catheter related infection and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, ventricular tachycardia. Maxipime dosage: . During the same period patient was treated with SIGMART (View Sigmart Review and Sigmart Label ), HUSTAZOL (View Hustazol Review and Hustazol Label ), GRAMALIL (View Gramalil Review and Gramalil Label ), TAKEPRON (View Takepron Review and Takepron Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HIRNAMIN (View Hirnamin Review and Hirnamin Label ), FRANDOL TAPE S (View Frandol Tape S Review and Frandol Tape S Label ), PROCYLIN (View Procylin Review and Procylin Label ).

5322032-1 | Burning Sensation, Infusion Related Reaction, Rash
Patient was taking Maxipime (View Usage). Patient had the following side effects: burning sensation, infusion related reaction, rash (What is rash?) on May 08, 2007 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 170.0 lb, was diagnosed with arthritis bacterial and. Maxipime dosage: 1gm Q12h Iv.

5316681-4 | Multi-organ Failure
Adverse event was reported on Apr 25, 2007 by a Female patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with lung infection, genitourinary tract infection and. Location: AUSTRIA , 77 years of age, weighting 264.6 lb, After Maxipime was administered, patient had the following side effects: multi-organ failure. During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

5316680-2 |
on Apr 25, 2007 Male patient from AUSTRIA , 65 years of age, weighting 154.3 lb, was diagnosed with respiratory tract infection, wound (What is wound?), sepsis (What is sepsis?) and was treated with Maxipime (View Usage). . Maxipime dosage: . During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ).

5316638-3 | Cardiac Failure
on Apr 27, 2007 Female patient from AUSTRIA , 83 years of age, was diagnosed with respiratory tract infection and was treated with Maxipime (View Usage). Patient had the following side effects: cardiac failure. Maxipime dosage: .

5316637-1 | Multimorbidity
Patient was taking Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: multimorbidity on Apr 27, 2007 from AUSTRIA Additional patient health information: Female patient , 82 years of age, weighting 253.5 lb, was diagnosed with respiratory tract infection, abdominal infection and. Maxipime dosage: . During the same period patient was treated with ZYVOX (View Zyvox Review and Zyvox Label ).

5306926-9 | Eosinophilia
Adverse event was reported on Apr 23, 2007 by a Male patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), nasopharyngitis and. Location: JAPAN , 82 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), GASTER D (View Gaster D Review and Gaster D Label ), AMBROXOL HCL (View Ambroxol Hcl Review and Ambroxol Hcl Label ), BROCIN (View Brocin Review and Brocin Label ), APRICOT KERNEL WATER (View Apricot Kernel Water Review and Apricot Kernel Water Label ), SENEGA ROOT (View Senega Root Review and Senega Root Label ), PROMAC (View Promac Review and Promac Label ), TIENAM (View Tienam Review and Tienam Label ). Patient was hospitalized.

5304730-9 | Haematuria, Mucocutaneous Ulceration, Stevens-johnson Syndrome
on Apr 18, 2007 Female patient from JAPAN , 87 years of age, was diagnosed with cholangitis and was treated with Maxipime (View Usage). Patient had the following side effects: haematuria, mucocutaneous ulceration, stevens-johnson syndrome. Maxipime dosage: . During the same period patient was treated with KN SOLUTION MG3 (View Kn Solution Mg3 Review and Kn Solution Mg3 Label ), VITAMEDIN (View Vitamedin Review and Vitamedin Label ), FULCALIQ 3 (View Fulcaliq 3 Review and Fulcaliq 3 Label ). Patient was hospitalized.

5296524-8 | Haematuria, Mucocutaneous Ulceration
on Apr 11, 2007 Female patient from JAPAN , 87 years of age, was diagnosed with cholangitis and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: haematuria, mucocutaneous ulceration. Maxipime dosage: . During the same period patient was treated with KN SOLUTION MG3 (View Kn Solution Mg3 Review and Kn Solution Mg3 Label ), VITAMEDIN (View Vitamedin Review and Vitamedin Label ), FULCALIQ 3 (View Fulcaliq 3 Review and Fulcaliq 3 Label ). Patient was hospitalized.

5282987-0 | Convulsion, Depressed Level Of Consciousness, Respiratory Failure
Patient was taking Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, depressed level of consciousness, respiratory failure on Mar 29, 2007 from JAPAN Additional patient health information: Female patient , 83 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Maxipime dosage: . Patient was hospitalized.

5282986-9 | Pruritus, Rash
Adverse event was reported on Mar 29, 2007 by a Female patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with respiratory disorder, prophylaxis and. Location: SPAIN , 76 years of age, Patient had the following side effects: pruritus, rash (What is rash?). During the same period patient was treated with AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), KLEXANE (View Klexane Review and Klexane Label ), VOLUVEN (View Voluven Review and Voluven Label ). Patient was hospitalized.

5281573-6 | Convulsion, Ventricular Tachycardia
on Mar 26, 2007 Female patient from JAPAN , 77 years of age, was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: convulsion, ventricular tachycardia. Maxipime dosage: .

5273549-X | Rash
on Mar 21, 2007 Male patient from UNITED STATES , weighting 196.0 lb, was diagnosed with streptococcal infection (What is streptococcal infection?) and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Maxipime dosage: 2gm Every 12 Hours Iv Bolus. During the same period patient was treated with EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), VICODIN (View Vicodin Review and Vicodin Label ), TYLENOL (View Tylenol Review and Tylenol Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), MAVIK (View Mavik Review and Mavik Label ), MILK OF MAG (View Milk Of Mag Review and Milk Of Mag Label ).

5272319-6 | Rash Maculo-papular, Rash Pruritic
Patient was taking Maxipime (View Usage). Patient had the following side effects: rash maculo-papular, rash pruritic on Mar 20, 2007 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 139.3 lb, was diagnosed with osteomyelitis and. Maxipime dosage: 1gm Every 12 Hours Iv. During the same period patient was treated with STERILE WATER FOR INJECTION (10ml) (View Sterile Water For Injection Review and Sterile Water For Injection Label ).

5258548-6 | Cardiac Failure, Coma, Status Epilepticus
Adverse event was reported on Mar 02, 2007 by a Female patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: SWITZERLAND , 95 years of age, After Maxipime was administered, patient had the following side effects: cardiac failure, coma, status epilepticus. During the same period patient was treated with ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), NITRODERM PATCH (View Nitroderm Patch Review and Nitroderm Patch Label ), ELTROXIN (View Eltroxin Review and Eltroxin Label ).

5256042-X | Disorientation, Fall, Foot Fracture, Myoclonus
on Mar 02, 2007 Male patient from UNITED STATES , weighting 224.9 lb, was diagnosed with pseudomonas infection and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: disorientation, fall (What is fall?), foot fracture, myoclonus. Maxipime dosage: 2g/100m/ns Bid Iv. Patient was hospitalized.

5254856-3 | Depressed Level Of Consciousness, Extrapyramidal Disorder, Pseudomembranous Colitis
on Feb 20, 2007 Female patient from JAPAN , 85 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Maxipime (View Usage). Patient had the following side effects: depressed level of consciousness, extrapyramidal disorder, pseudomembranous colitis. Maxipime dosage: . During the same period patient was treated with THEOLONG (View Theolong Review and Theolong Label ), MEPTIN (View Meptin Review and Meptin Label ), ENOXACIN (View Enoxacin Review and Enoxacin Label ), KREMEZIN (View Kremezin Review and Kremezin Label ), DIPROPHYLLINE (View Diprophylline Review and Diprophylline Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), FERROMIA (View Ferromia Review and Ferromia Label ), MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

5254526-1 | Eosinophilia
Patient was taking Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: eosinophilia on Feb 20, 2007 from JAPAN Additional patient health information: Male patient , 82 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Maxipime dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), GASTER D (View Gaster D Review and Gaster D Label ), AMBROXOL HCL (View Ambroxol Hcl Review and Ambroxol Hcl Label ), BROCIN (View Brocin Review and Brocin Label ), APRICOT KERNEL WATER (View Apricot Kernel Water Review and Apricot Kernel Water Label ), SENEGA ROOT (View Senega Root Review and Senega Root Label ), PROMAC (View Promac Review and Promac Label ), TIENAM (View Tienam Review and Tienam Label ). Patient was hospitalized.

5248011-0 | Anaphylactic Shock, Cardio-respiratory Arrest, Multi-organ Failure
Adverse event was reported on Feb 16, 2007 by a Female patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with acute abdomen and. Location: JAPAN , 59 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cardio-respiratory arrest, multi-organ failure. During the same period patient was treated with MALTOSE + LACTATED RINGERS SOLUTION (View Maltose + Lactated Ringers Solution Review and Maltose + Lactated Ringers Solution Label ).

5248004-3 | Blood Pressure Decreased, Vomiting
on Feb 16, 2007 Female patient from JAPAN , 46 years of age, was diagnosed with tonsillitis and was treated with Maxipime (View Usage). Patient had the following side effects: blood pressure decreased, vomiting. Maxipime dosage: .

5223859-7 | Encephalopathy, Somnolence
on Jan 25, 2007 Female patient from SWITZERLAND , 88 years of age, was diagnosed with diverticular perforation, prophylaxis and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: encephalopathy, somnolence. Maxipime dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), FLAGYL (View Flagyl Review and Flagyl Label ).

5203662-4 | Blast Cells Present, Dental Caries, Leukopenia, Myelofibrosis
Patient was taking Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: blast cells present, dental caries, leukopenia, myelofibrosis on Dec 28, 2006 from JAPAN Additional patient health information: Female patient , 42 years of age, weighting 121.3 lb, was diagnosed with dental caries, iron deficiency anaemia, chronic myeloid leukaemia and. Maxipime dosage: 2 G/day. During the same period patient was treated with FERROUS SULFATE TAB (160 Mg/day) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), GLEEVEC (300 Mg/day) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5191286-7 | Rash Pruritic
Adverse event was reported on Dec 20, 2006 by a Female patient taking Maxipime (View Usage) (Dosage: 2gm Every 12 Hours Iv) was diagnosed with lung infection pseudomonal and. Location: UNITED STATES , weighting 123.0 lb, Patient had the following side effects: rash pruritic. During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), XANAX (View Xanax Review and Xanax Label ), SINGULAIR (View Singulair Review and Singulair Label ), HUMIBID L.A. (View Humibid L.a. Review and Humibid L.a. Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), NEXIUM (View Nexium Review and Nexium Label ), VALTREX (View Valtrex Review and Valtrex Label ).

5182957-7 | Blast Cells Present, Dental Caries, Iron Deficiency Anaemia, Leukopenia, Myelofibrosis
on Oct 13, 2006 Female patient from JAPAN , 42 years of age, weighting 121.3 lb, was diagnosed with dental caries, iron deficiency anaemia, chronic myeloid leukaemia and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: blast cells present, dental caries, iron deficiency anaemia, leukopenia, myelofibrosis. Maxipime dosage: 2 G/day. During the same period patient was treated with FERROUS SULFATE TAB (160 Mg/day) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), GLEEVEC (300 Mg/day) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5164453-6 | Erythema, Feeling Hot, Pneumonia
on Nov 13, 2006 Female patient from JAPAN , 92 years of age, was diagnosed with pyrexia and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, feeling hot, pneumonia (What is pneumonia?). Maxipime dosage: . During the same period patient was treated with ELEMENMIC (View Elemenmic Review and Elemenmic Label ), HUMULIN R (View Humulin R Review and Humulin R Label ), LASIX (View Lasix Review and Lasix Label ), NEOPAREN (View Neoparen Review and Neoparen Label ).

5162956-1 | Confusional State, Convulsion, Cytomegalovirus Infection, Disorientation, Dyskinesia, Muscle Spasms, Pain, Speech Disorder, Visual Disturbance
Patient was taking Maxipime (View Usage). Patient had the following side effects: confusional state, convulsion, cytomegalovirus infection (What is cytomegalovirus infection?), disorientation, dyskinesia, muscle spasms, pain (What is pain?), speech disorder, visual disturbance on Nov 04, 2006 from BRAZIL Additional patient health information: Male patient , 54 years of age, was diagnosed with bronchitis acute and. Maxipime dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.